Condition
Neurofibromatosis Type 1 clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Neurofibromatosis Type 1 clinical trials that are recruiting, at sites in 3 countries (most in United States (5), France (1), Egypt (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest Neurofibromatosis Type 1 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How common NF1 is in Egypt and how it progresses and is treated | — | Al Mansurah and 8 other locations | Recruiting | Oct 27, 2025 |
| Assessing appearance concerns in Neurofibromatosis Type 1 patients | — | Bethesda, Maryland | Recruiting | Mar 18, 2025 |
| Evaluating HLX-1502 for Neurofibromatosis Type 1 | Phase 2 | Birmingham, Alabama and 13 other locations | Recruiting | Aug 7, 2024 |
| Pupillometry to measure pain and sensory problems in people with NF1 | — | Washington D.C., District of Columbia and 1 other locations | Recruiting | Jul 18, 2024 |
| Assessing the burden of rare skin diseases | — | Bobigny and 14 other locations | Recruiting | Jul 20, 2023 |
| Using advanced MRI and AI to find early signs of cancer in children with Neurofibromatosis Type 1 | — | Los Angeles, California | Recruiting | Feb 21, 2021 |
| Investigating genetic factors in childhood cancer | — | Memphis, Tennessee | Recruiting | Feb 10, 2017 |
All recruiting trials (7)
-
How common NF1 is in Egypt and how it progresses and is treated
This project will look at people in Egypt with neurofibromatosis type 1 to see how common it is, what symptoms they have, how it changes over time, and how it is managed.
-
Assessing appearance concerns in Neurofibromatosis Type 1 patients
This study is trying to understand how appearance-related concerns affect people with Neurofibromatosis Type 1 by gathering their thoughts and experiences through questionnaires and discussions.
-
Evaluating HLX-1502 for Neurofibromatosis Type 1
This study is testing a new treatment called HLX-1502 to see if it can help adults with Neurofibromatosis Type 1 who have growing or painful tumors.
-
Pupillometry to measure pain and sensory problems in people with NF1
This study will test whether the AlgometRx Nociometer, a pupillometry device, can measure pain and other sensory problems in children and adults with NF1.
-
Assessing the burden of rare skin diseases
This study is trying to understand how nine rare skin diseases affect the daily lives of patients and their families, including their emotional, social, and financial challenges.
-
Using advanced MRI and AI to find early signs of cancer in children with Neurofibromatosis Type 1
This study is trying to see if advanced MRI scans and artificial intelligence can help find early signs of cancer in children with Neurofibromatosis Type 1.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
Related topics
Quick answers
How many Neurofibromatosis Type 1 clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (5 trials), France (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.